EGFR and neoplasm: Previous studies showed that ctDNA analysis discovered genomic changes in genes RAS, BRAF, ERBB2, MET, and other tumor‐related genes associated with resistance to anti‐epidermal growth factor receptor (EGFR) therapy could have higher diagnostic accuracy.12